Efficacy and Safety Profile of Tricyclo-DNA Antisense Oligonucleotides in Duchenne Muscular Dystrophy Mouse Model
Antisense oligonucleotides (AONs) hold promise for therapeutic splice-switching correction in many genetic diseases. However, despite advances in AON chemistry and design, systemic use of AONs is limited due to poor tissue uptake and sufficient therapeutic efficacy is still difficult to achieve. A n...
Saved in:
Main Authors: | Karima Relizani (Author), Graziella Griffith (Author), Lucía Echevarría (Author), Faouzi Zarrouki (Author), Patricia Facchinetti (Author), Cyrille Vaillend (Author), Christian Leumann (Author), Luis Garcia (Author), Aurélie Goyenvalle (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficient SMN Rescue following Subcutaneous Tricyclo-DNA Antisense Oligonucleotide Treatment
by: Valérie Robin, et al.
Published: (2017) -
Emotional behavior and brain anatomy of the mdx52 mouse model of Duchenne muscular dystrophy
by: Amel Saoudi, et al.
Published: (2021) -
Partial restoration of brain dystrophin by tricyclo-DNA antisense oligonucleotides alleviates emotional deficits in mdx52 mice
by: Amel Saoudi, et al.
Published: (2023) -
Evaluation of 2'-Deoxy-2'-fluoro Antisense Oligonucleotides for Exon Skipping in Duchenne Muscular Dystrophy
by: Silvana M G Jirka, et al.
Published: (2015) -
In Vitro Studies to Evaluate the Intestinal Permeation of an Ursodeoxycholic Acid-Conjugated Oligonucleotide for Duchenne Muscular Dystrophy Treatment
by: Marika Faiella, et al.
Published: (2024)